Annual Net Margin
-138.43%
+130.44%+48.51%
31 December 2023
Summary:
Revance Therapeutics annual net profit margin is currently -138.43%, with the most recent change of +130.44% (+48.51%) on 31 December 2023. During the last 3 years, it has risen by +223.16% (+61.72%). RVNC annual net margin is now at all-time high.RVNC Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Margin
-63.65%
-6.34%-11.06%
30 September 2024
Summary:
Revance Therapeutics quarterly net profit margin is currently -63.65%, with the most recent change of -6.34% (-11.06%) on 30 September 2024. Over the past year, it has increased by +6.20% (+8.88%). RVNC quarterly net margin is now -11.06% below its all-time high of -57.31%, reached on 30 June 2024.RVNC Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RVNC Net Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +8.9% |
| 3 y3 years | +61.7% | +73.8% |
| 5 y5 years | +99.6% | +99.9% |
RVNC Net Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +61.7% | -11.1% | +78.2% |
| 5 y | 5 years | at high | +99.6% | -11.1% | +99.9% |
| alltime | all time | at high | +99.7% | -11.1% | +99.9% |
Revance Therapeutics Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -63.65%(+11.1%) |
| June 2024 | - | -57.31%(-44.0%) |
| Mar 2024 | - | -102.34%(+46.5%) |
| Dec 2023 | -138.43%(-48.5%) | -69.85%(-73.2%) |
| Sept 2023 | - | -260.90%(+111.1%) |
| June 2023 | - | -123.60%(-5.4%) |
| Mar 2023 | - | -130.63%(-55.3%) |
| Dec 2022 | -268.87%(-25.6%) | -292.37%(+0.2%) |
| Sept 2022 | - | -291.89%(+34.1%) |
| June 2022 | - | -217.72%(-14.5%) |
| Mar 2022 | - | -254.71%(+4.8%) |
| Dec 2021 | -361.59%(-80.4%) | -243.15%(-35.4%) |
| Sept 2021 | - | -376.68%(-1.9%) |
| June 2021 | - | -383.94%(-28.7%) |
| Mar 2021 | - | -538.68%(-23.4%) |
| Dec 2020 | -1840.71%(-95.2%) | -703.40%(-66.8%) |
| Sept 2020 | - | -2118.83%(-89.5%) |
| June 2020 | - | -20.26 K%(-81.0%) |
| Mar 2020 | - | -106.78 K%(+109.7%) |
| Dec 2019 | -38.60 K%(+909.7%) | -50.93 K%(-43.4%) |
| Sept 2019 | - | -90.02 K%(+608.9%) |
| Mar 2019 | - | -12.70 K%(+52.3%) |
| Dec 2018 | -3823.22% | -8340.04%(+500.0%) |
| Sept 2018 | - | -1390.09%(-72.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2018 | - | -4967.93%(-72.6%) |
| Mar 2018 | - | -18.15 K%(-81.3%) |
| Dec 2017 | -46.03 K%(+54.7%) | -97.05 K%(+137.5%) |
| Sept 2017 | - | -40.87 K%(+14.1%) |
| June 2017 | - | -35.83 K%(-1.0%) |
| Mar 2017 | - | -36.21 K%(+1.3%) |
| Dec 2016 | -29.76 K%(+21.5%) | -35.74 K%(+49.1%) |
| Sept 2016 | - | -23.97 K%(-26.9%) |
| June 2016 | - | -32.80 K%(+23.7%) |
| Mar 2016 | - | -26.52 K%(-10.0%) |
| Dec 2015 | -24.49 K%(+49.1%) | -29.46 K%(+15.2%) |
| Sept 2015 | - | -25.57 K%(+14.1%) |
| June 2015 | - | -22.41 K%(+9.1%) |
| Mar 2015 | - | -20.54 K%(+8.4%) |
| Dec 2014 | -16.43 K%(+93.3%) | -18.95 K%(+1.7%) |
| Sept 2014 | - | -18.64 K%(+5.1%) |
| June 2014 | - | -17.74 K%(+30.8%) |
| Mar 2014 | - | -13.56 K%(+315.7%) |
| Dec 2013 | -8500.49%(+4.6%) | -3261.81%(-42.0%) |
| Sept 2013 | - | -5622.15%(-64.4%) |
| June 2013 | - | -15.77 K%(-45.4%) |
| Mar 2013 | - | -28.88 K%(+209.9%) |
| Dec 2012 | -8125.38%(+0.9%) | -9317.09% |
| Dec 2011 | -8054.40% | - |
FAQ
- What is Revance Therapeutics annual net profit margin?
- What is the all time high annual net margin for Revance Therapeutics?
- What is Revance Therapeutics quarterly net profit margin?
- What is the all time high quarterly net margin for Revance Therapeutics?
- What is Revance Therapeutics quarterly net margin year-on-year change?
What is Revance Therapeutics annual net profit margin?
The current annual net margin of RVNC is -138.43%
What is the all time high annual net margin for Revance Therapeutics?
Revance Therapeutics all-time high annual net profit margin is -138.43%
What is Revance Therapeutics quarterly net profit margin?
The current quarterly net margin of RVNC is -63.65%
What is the all time high quarterly net margin for Revance Therapeutics?
Revance Therapeutics all-time high quarterly net profit margin is -57.31%
What is Revance Therapeutics quarterly net margin year-on-year change?
Over the past year, RVNC quarterly net profit margin has changed by +6.20% (+8.88%)